These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 2995723)
21. Growth factors in cancer and their relationship to oncogenes. Salomon DS; Perroteau I Cancer Invest; 1986; 4(1):43-60. PubMed ID: 3006881 [No Abstract] [Full Text] [Related]
22. Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Valverius EM; Bates SE; Stampfer MR; Clark R; McCormick F; Salomon DS; Lippman ME; Dickson RB Mol Endocrinol; 1989 Jan; 3(1):203-14. PubMed ID: 2783757 [TBL] [Abstract][Full Text] [Related]
23. [In vitro properties of various growth factors and in vivo effects]. Courty J; Courtois Y; Barritault D Biochimie; 1984 Jun; 66(6):419-28. PubMed ID: 6093893 [TBL] [Abstract][Full Text] [Related]
24. Cytokines and human malignant melanoma. Immuno- and growth-regulatory peptides in melanoma biology. Köck A; Schwarz T; Micksche M; Luger TA Cancer Treat Res; 1991; 54():41-66. PubMed ID: 1673859 [No Abstract] [Full Text] [Related]
25. A high-molecular-weight PDGF-like factor secreted by v-sis transformed cells leads to growth stimulation and transformation. Klein R; Thiel HJ Oncogene Res; 1988 May; 2(4):311-24. PubMed ID: 2840622 [TBL] [Abstract][Full Text] [Related]
26. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Roberts AB; Anzano MA; Wakefield LM; Roche NS; Stern DF; Sporn MB Proc Natl Acad Sci U S A; 1985 Jan; 82(1):119-23. PubMed ID: 3871521 [TBL] [Abstract][Full Text] [Related]
27. Concomitant synthesis of growth factors and their receptors--an aspect of malignant transformation. Alexander P; Currie G Biochem Pharmacol; 1984 Mar; 33(6):941-3. PubMed ID: 6324807 [TBL] [Abstract][Full Text] [Related]
28. Signal transduction cascade shared by epidermal growth factor and platelet-derived growth factor is a major pathway for oncogenic transformation in NRK cells. Masuda A; Kizaka-Kondoh S; Miwatani H; Terada Y; Nojima H; Okayama H New Biol; 1992 May; 4(5):489-503. PubMed ID: 1515413 [TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of the anchorage-independent growth of myc-transfected fibroblasts by retinoic acid. Roberts AB; Roche NS; Sporn MB Nature; 1985 May 16-22; 315(6016):237-9. PubMed ID: 2987698 [TBL] [Abstract][Full Text] [Related]
30. Autocrine growth factors and solid tumor malignancy. Walsh JH; Karnes WE; Cuttitta F; Walker A West J Med; 1991 Aug; 155(2):152-63. PubMed ID: 1926844 [TBL] [Abstract][Full Text] [Related]
31. [Microbiological approach to the treatment of brain tumors]. Kuratsu J; Ushio Y Gan To Kagaku Ryoho; 1991 Feb; 18(2):195-200. PubMed ID: 1992913 [TBL] [Abstract][Full Text] [Related]
32. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes. Vennström B; Bravo R Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775 [TBL] [Abstract][Full Text] [Related]
33. PDGF-like growth factor induces EGF-potentiated phenotypic transformation of normal rat kidney cells in the absence of TGF beta. van Zoelen EJ; van Oostwaard TM; de Laat SW Biochem Biophys Res Commun; 1986 Dec; 141(3):1229-35. PubMed ID: 3492998 [TBL] [Abstract][Full Text] [Related]
34. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors. Todaro GJ; De Larco JE; Fryling CM Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003 [TBL] [Abstract][Full Text] [Related]
36. The molecular biology of platelet-derived growth factor. Stiles CD Cell; 1983 Jul; 33(3):653-5. PubMed ID: 6307524 [TBL] [Abstract][Full Text] [Related]
37. Presence of transforming growth factors in human breast cancer cells. Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663 [TBL] [Abstract][Full Text] [Related]